| 高雄醫學大學 |
1997 |
Tamm-Horsfall glycoprotein (THG) is a binder for surface membrane proteins on blood cells and glomerular mesangial cells.
|
余家利;蔡昌友;孫光蕙;謝松洲;余幸司;韓韶華 |
| 臺大學術典藏 |
2021-01-27T01:38:41Z |
Tamm-Horsfall glycoprotein (THG) purified from normal human pregnancy urine increases phagocytosis, complement receptor expressions and arachidonic acid metabolism of polymorphonuclear neutrophils
|
CHIA-LI YU; Lin W.-M.; Liao T.-S.; Tsai C.-Y.; Sun K.-H.; Chen K.-H. |
| 臺大學術典藏 |
2021-01-27T01:38:08Z |
Tamm-horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
|
Siao S.-C.;Li K.-J.;Hsieh S.-C.;Wu C.-H.;Lu M.-C.;Tsai C.-Y.;Chia-Li Yu; Siao S.-C.; Li K.-J.; Hsieh S.-C.; Wu C.-H.; Lu M.-C.; Tsai C.-Y.; CHIA-LI YU |
| 臺大學術典藏 |
2022-02-10T05:27:17Z |
Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
|
Siao, Syue-Cian; KO-JEN LI; Hsieh, Song-Chou; Wu, Cheng-Han; Lu, Ming-Chi; Tsai, Chang-Youh; Yu, Chia-Li |
| 臺大學術典藏 |
2021-02-01T00:49:05Z |
Tamm-horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
|
Siao S.-C.; KO-JEN LI; Hsieh S.-C.; Wu C.-H.; Lu M.-C.; Tsai C.-Y.; Yu C.-L. |
| 臺大學術典藏 |
2021-01-15T02:46:27Z |
Tamm-horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
|
Siao S.-C.; Li K.-J.; SONG-CHOU HSIEH; Wu C.-H.; Lu M.-C.; Tsai C.-Y.; Yu C.-L. |
| 臺大學術典藏 |
2022-02-09T08:55:59Z |
Tamm-Horsfall Protein is a Potent Immunomodulatory Molecule and a Disease Biomarker in the Urinary System
|
Wu, Tsai-Hung; KO-JEN LI; Yu, Chia-Li; Tsai, Chang-Youh |
| 臺大學術典藏 |
2021-01-27T01:38:40Z |
Tamm-Horsfall urinary glycoprotein enhances monokine release and augments lymphocyte proliferation
|
CHIA-LI YU; Tsai C.-Y.; Lin W.-M.; Liao T.-S.; Chen H.-L.; Sun K.-H.; Chen K.-H. |
| 國立成功大學 |
2023-02 |
Tamm-Plasmon Exciton-Polaritons in Single-Monolayered CsPbBr3 Quantum Dots at Room Temperature
|
Yen;Meng-Cheng;Lee;Chia-Jung;Yao;Yung-Chi;Chen;Yuan-Ling;Wu;Sheng-Chan;Hsu;Hsu-Cheng;Kajino;Yuto;Lin;Gong-Ru;Tamada;Kaoru;Lee;Ya-Ju |
| 元培科技大學 |
2008 |
TAMMAC:An Adaptive Multi-Channel MAC Protocol for MANETs
|
Jen-Chu Liu; Wen-Tsuen Chen; Ting-Kai Huang; Yu-Chu Chang |
| 臺大學術典藏 |
2021-01-27T01:37:58Z |
Tamm–Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system
|
Wu T.-H.;Li K.-J.;Chia-Li Yu;Tsai C.-Y.; Wu T.-H.; Li K.-J.; CHIA-LI YU; Tsai C.-Y. |
| 臺大學術典藏 |
2021-02-01T00:48:54Z |
Tamm–Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system
|
Wu T.-H.; KO-JEN LI; Yu C.-L.; Tsai C.-Y. |
| 臺大學術典藏 |
2022-01-25T08:15:23Z |
Tamm–Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system
|
Wu T.-H.; KO-JEN LI; Yu C.-L.; Tsai C.-Y. |
| 國立交通大學 |
2018-01-24T07:43:24Z |
Tamm電漿子偵測環境折射率之研究
|
黃炫貴; 鄭協昌; Huang, Syuan-Guei |
| 臺大學術典藏 |
2020-05-25T06:51:44Z |
Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis
|
Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D. |
| 國家衛生研究院 |
2007-11-15 |
Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells
|
Kuo, CC; Liu, JF; Shiah, HS; Ma, LC; Chang, JY |
| 臺大學術典藏 |
2018-09-10T03:31:22Z |
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice
|
Wu, W-M; Suen, J-L; Lin, B-F; Chiang, B-L; Wu, W-M; BOR-LUEN CHIANG; BI-FONG LIN; Suen, J-L; Lin, B-F; Chiang, B-L |
| 國立臺灣大學 |
2000 |
Tamoxifen Alleviates Disease Severity and Decreases Double Negative T Cells in Autoimmune Mrl-Lpr/Lpr Mice
|
江伯倫; CHIANG, BOR-LUEN |
| 國立臺灣大學 |
2000 |
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice
|
Wu, W-M; Suen, J-L; Lin, B-F; Chiang, B-L |
| 臺大學術典藏 |
2020-06-27T06:40:20Z |
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice
|
Wu W.-M.;Suen J.-L.;Lin B.-F.;Bor-Luen Chiang; Wu W.-M.; Suen J.-L.; Lin B.-F.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:51Z |
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice
|
Wu W.-M.; Suen J.-L.; Lin B.-F.; BOR-LUEN CHIANG |
| 國立臺灣大學 |
2000-01 |
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL.lpr/lpr mice
|
Wu WM; Suen JL; 林璧鳳; Chiang BL; Wu WM; Suen JL; Lin BF; Chiang BL |
| 國立臺北護理健康大學 |
2017-12 |
Tamoxifen and the Risk of Parkinson's Disease in Female Patients with Breast Cancer in Asian People: A Nationwide Population-Based Study
|
Hong, Chien Tai; Chan, Lung; Hu, Chaur Jong; Lin, Chien Min; Hsu, Chien Yeh; Lin, Ming Chin |
| 臺大學術典藏 |
2018-09-10T03:31:22Z |
Tamoxifen decreases renal inflammation and alleviates disease severity autoimmune NZB/W F1 mice
|
Wu, W.-M.; Lin, B.-F.; Su, Y.-C.; Suen, J.-L.; Chiang, B.-L.; Wu, W.-M.; BOR-LUEN CHIANG; Lin, B.-F.; BI-FONG LIN; Su, Y.-C.; Suen, J.-L.; Chiang, B.-L. |
| 臺大學術典藏 |
2020-06-27T06:40:19Z |
Tamoxifen decreases renal inflammation and alleviates disease severity autoimmune NZB/W F1 mice
|
Wu W.-M.;Lin B.-F.;Su Y.-C.;Suen J.-L.;Bor-Luen Chiang; Wu W.-M.; Lin B.-F.; Su Y.-C.; Suen J.-L.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:49Z |
Tamoxifen decreases renal inflammation and alleviates disease severity autoimmune NZB/W F1 mice
|
Wu W.-M.; Lin B.-F.; Su Y.-C.; Suen J.-L.; BOR-LUEN CHIANG |
| 國立臺灣大學 |
2000 |
Tamoxifen Decreases Renal Inflammation and Alleviates Disease Severity in Autoimmune
|
江伯倫; CHIANG, BOR-LUEN |
| 國立臺灣大學 |
2000 |
Tamoxifen Decreases Renal Inflammation and Alleviates Disease Severity in Autoimmune NZB/W F1 Mice
|
Wu, W.-M.; Lin, B.-F.; Su, Y.-C.; Suen, J.-L.; Chiang, B.-L. |
| 國立臺灣大學 |
2000 |
Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice.
|
吳文勉; 林璧鳳; 江伯倫 |
| 臺大學術典藏 |
2018-09-10T08:29:54Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang, J.-W. and Yen, C.-J. and Wu, H.-Y. and Chiang, C.-K. and Cheng, H.-T. and Lien, Y.-C. and Hung, K.-Y. and Tsai, T.-J.; CHIH-KANG CHIANG; CHUNG-JEN YEN; TUN-JUN TSAI; JENQ-WEN HUANG; KUAN-YU HUNG; HUI-TENG CHENG |
| 臺大學術典藏 |
2020-10-14T06:31:01Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Tsai T.-J.; Hung K.-Y.; Cheng H.-T.; Lien Y.-C.; Chiang C.-K.; Wu H.-Y.; CHUNG-JEN YEN; Huang J.-W. |
| 臺大學術典藏 |
2020-11-27T03:24:40Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.;Yen C.-J.;Wu H.-Y.;Chiang C.-K.;Cheng H.-T.;Lien Y.-C.;Kuan-Yu Hung;Tsai T.-J.; Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; KUAN-YU HUNG; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Wu H.-Y.; Yen C.-J.; JENQ-WEN HUANG; Jenq-Wen Huang ;Yen C.-J. ;Wu H.-Y. ;Chiang C.-K. ;Cheng H.-T. ;Lien Y.-C. ;Hung K.-Y. ;Tsai T.-J.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; Hung K.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:43:45Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; Hung K.-Y.; TUN-JUN TSAI |
| 臺大學術典藏 |
2021-03-15T08:26:18Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; HUI-TENG CHENG; Lien Y.-C.; Hung K.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2021-03-15T08:46:56Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; HUI-TENG CHENG; Lien Y.-C.; Hung K.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2021-05-27T09:06:57Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; CHIH-KANG CHIANG; Cheng H.-T.; Lien Y.-C.; Hung K.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:16Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; KUAN-YU HUNG; Tsai T.-J. |
| 臺大學術典藏 |
2021-03-03T07:53:29Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
HUI-TENG CHENG |
| 國立交通大學 |
2014-12-08T15:35:29Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, Jen-Chung; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T14:53:50Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Jian, Y.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Lin, Y.-W.; JEN-CHUNG KO; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:24Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:38Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:47Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
1995 |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Chang-Yao Hsieh;Su I.-J.;Lai M.-K.; Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; CHANG-YAO HSIEH; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-02-02T00:47:12Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Yeong-Shiau Pu;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Hsieh C.-Y.;Su I.-J.;Lai M.-K.; YEONG-SHIAU PU; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-09-01T02:02:44Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 國家衛生研究院 |
2020-05-29 |
Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial
|
Chen, PC;Hsieh, YC;Huang, CC;Hu, CJ |
| 國立交通大學 |
2015-07-21T11:20:28Z |
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells
|
Liu, Chun-Yu; Hung, Man-Hsin; Wang, Duen-Shian; Chu, Pei-Yi; Su, Jung-Chen; Teng, Tsung-Han; Huang, Chun-Teng; Chao, Ting-Ting; Wang, Cheng-Yi; Shiau, Chung-Wai; Tseng, Ling-Ming; Chen, Kuen-Feng |
